Drawing for Serial No. 88361523

USPTO serial 88361523

Serial No. 88361523

Reviewed by CopyMark Law Group

Reg. 7236686Status 700Registered
Filing date
Status date
Registration date
Dec 5, 2023
Examiner
SPARACINO, MARK V
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 88361523?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical reagents and RNA sequences being chemical reagents for agricultural purposes and not medical or veterinary purposes, namely, for crop protection and to improve plant health; Seed coatings and chemical treatments applied to rice, wheat, sorghum, maize, sugar cane, sunflower, potato, canola, buckwheat, cotton, soybeans, sugar beets, tomato, and wheat seeds to improve crop health and yield; flower chemical treatments applied to carnations, roses, and tulips to improve flower health and longevityACTIVE—
005Chemical reagents and RNA sequences being chemical reagents used to repel or destroy pests and vermin; Agricultural products, namely, herbicides, pesticides, fungicides; preparations for destroying vermin; Pharmaceutical products, aquaculture products, and veterinary products for human, aquaculture, and animal health in the nature of vaccines and RNA therapeutics for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancer; Antibiotics; Vaccines; Gene therapy products, namely, mRNA therapeutics and siRNA therapeutics for medical or clinical use for the treatment of infectious diseases, respiratory diseases, immune system diseases, cardiovascular diseases, and cancer; RNA in the nature of vaccines and therapeutics for scientific, research, medical, pharmaceutical, veterinary, agricultural, aquaculture, chemical and energy production, industrial and manufacturing use for the treatment of infectious diseases, neurological diseases, metabolic diseases, cardiovascular diseases, respiratory diseases, immune system diseases, and cancerACTIVE—
040Cell-Free processing and manufacturing for the production of food, beverages, and sugars for others; Cell-Free processing and manufacturing of RNA for others; manufacturing and processing of RNA for others for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; biological manufacturing and cell-free processing of RNA for others; manufacturing and processing of RNA delivery formulations for others for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing useACTIVEMar 10, 2019
042Research and development services in the field of RNA for scientific, engineering, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing use; research and development services in the field of synthetic and recombinant biology and formulations; design and engineering in the field of producing RNA and cell-free processing; research and development services in the field of producing, manufacturing, and processing of RNA and RNA formulations for scientific, research, medical, pharmaceutical, veterinary, agricultural food, chemical and energy production, industrial and manufacturing use; research and development services in the field of formulations for the delivery of RNA for scientific, research, medical, pharmaceutical, veterinary, agricultural, chemical and energy production, industrial and manufacturing useACTIVEMar 10, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 5, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 31, 2023EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Oct 31, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 30, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 17, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 6, 2023IUAFUSE AMENDMENT FILED—
Oct 6, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2023EX5GSOU EXTENSION 5 GRANTED—
Apr 6, 2023EXT5SOU EXTENSION 5 FILED—
Apr 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2022EX4GSOU EXTENSION 4 GRANTED—
Oct 4, 2022EXT4SOU EXTENSION 4 FILED—
Oct 4, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2022EX3GSOU EXTENSION 3 GRANTED—
Apr 6, 2022EXT3SOU EXTENSION 3 FILED—
Apr 6, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 13, 2021EX2GSOU EXTENSION 2 GRANTED—
Oct 13, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 5, 2021EXT2SOU EXTENSION 2 FILED—
Oct 5, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 6, 2021EX1GSOU EXTENSION 1 GRANTED—
Apr 6, 2021EXT1SOU EXTENSION 1 FILED—
Apr 6, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 9, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 9, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 9, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 9, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 9, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 9, 2020RDX3NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED—
Jul 9, 2020RDX1ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED—
Jul 9, 2020RRDXACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED—
Jun 30, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 29, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jan 6, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jan 6, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 6, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 16, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 16, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 16, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 30, 2019DOCKASSIGNED TO EXAMINER—
Jun 14, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 14, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 7, 2019DOCKASSIGNED TO EXAMINER—
Apr 18, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance